RxDoctor Payments Data

Linda Martinez

Adult Medicine · Doral, FLNPI 1821411745

Payments from drug & device makers

What this record shows

Every reported general payment came from a single manufacturer, Novartis.

$543in general payments, 2019–2025

Across 4 payments — averaging $135.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$543
$2,111,205in research payments, 2019–2025

Across 213 payments — averaging $9911.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astrazeneca UK Limited$829K
  • UCB SA$562K
  • Taro Pharmaceuticals USA, Inc.$360K
  • Intercept Pharmaceuticals, Inc.$196K
  • Royal Biologics, Inc.$54K
  • Intercept Pharma Europe Ltd.$43K
  • plus $67K from 5 others

What the payments were for

  • Travel & lodging$28753%
  • Food & beverage$25747%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis4$543

How this compares

$543 in reported general payments places this provider in the 55th percentile of 195 adult medicine providers in Florida.

See all adult medicine providers in Florida →

Other adult medicine in Doral

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →